Oil from Antarctic krill (Euphausia superba) facilitates bone formation in dexamethasone-treated mice
Authors:
- 14 September 2018
- journal article
- research article
- Published by Springer Nature in Food Science and Biotechnology
- Vol. 28 (2) , 539-545
Abstract
Glucocorticoids are the leading cause of secondary osteoporosis. In the current study, the in vivo effects of Antarctic krill (Euphausia superba) oil (AKO) on dexamethasone-treated mice were investigated. Results showed that AKO significantly prevents bone loss, as evidenced by improved bone mineral density, biomechanical strength, and cancellous bone microstructure. Fluorescence double-labeling of femur showed that AKO induces new bone formation. Toluidine blue staining of marrow cavity indicated that AKO increases the number of trabecula, and decreases the generation of adipose cells. Runt-related transcription factor 2 (Runx2) and Peroxisome proliferator-activated receptor γ (PPARγ) are the switches for osteogenic and adipogenic differentiation of bone marrow mesenchymal stem cells, respectively. AKO significantly promoted the expression of Runx2 protein, and reduced PPARγ expression in bone tissue. Furthermore, AKO increased the mRNA expression of osteogenesis-related genes and decreased the expression of adipogenesis-related genes. In conclusion, AKO improved glucocorticoid-induced osteoporosis via promoting bone formation.Keywords
Funding Information
- Primary Research & Development Plan of Shandong Province (2016YYSP017)
- Key S&T Special Projects of Shandong Province (2015ZDZX05003)
- National key research and development program (2017YFF0207800)
This publication has 24 references indexed in Scilit:
- Dexamethasone shifts bone marrow stromal cells from osteoblasts to adipocytes by C/EBPalpha promoter methylationCell Death & Disease, 2013
- Cannabinoid receptor 1 regulates ERK and GSK-3β-dependent glucocorticoid inhibition of osteoblast differentiation in murine MC3T3-E1 cellsBone, 2011
- Supplementation with a low–moderate dose ofn-3 long-chain PUFA has no short-term effect on bone resorption in human adultsBritish Journal of Nutrition, 2010
- PPARγ: a circadian transcription factor in adipogenesis and osteogenesisNature Reviews Endocrinology, 2010
- Glucocorticoids Suppress Bone Formation by Attenuating Osteoblast Differentiation via the Monomeric Glucocorticoid ReceptorCell Metabolism, 2010
- Prostaglandins in bone: bad cop, good cop?Trends in Endocrinology & Metabolism, 2010
- Intermittent Parathyroid Hormone Administration Counteracts the Adverse Effects of Glucocorticoids on Osteoblast and Osteocyte Viability, Bone Formation, and Strength in MiceEndocrinology, 2010
- Glucocorticoid induces apoptosis of osteoblast cells through the activation of glycogen synthase kinase 3βJournal of Bone and Mineral Metabolism, 2008
- Long-Chain Polyunsaturated Fatty Acids and the Regulation of Bone MetabolismExperimental Biology and Medicine, 2007
- Tandem repeat of C/EBP binding sites mediates PPAR?2 gene transcription in glucocorticoid-induced adipocyte differentiationJournal of Cellular Biochemistry, 2000